A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...

Learn the five pillars of production-ready document AI and the questions buyers must ask to avoid costly rip-and-replace ...

The Nevada commission says one more strike and this former UFC fighter is out.

India head coach Gautam Gambhir faced criticism after Washington Sundar's underwhelming performance against South Africa in ...

The genetic engineering of 3000 sheep in NZ in the 1990s didn’t end particularly well. The ‘biopharming’ of plants, however, ...

This won’t be the year Utah approves an alternative exam to replace the RISE or Aspire tests in the state public school ...

Grail said Galleri, its multi-cancer early detection test, failed to meet the primary endpoint of a recent trial. The stock slid 47%, to $54.20, in after-hours trading. Through market close, share ...

Grail’s shares plummeted more than 45% after-hours Thursday as the medtech revealed a major National Health Service (NHS) ...

The Kansas City Chiefs have several NFL free agency decisions to make at wide receiver, and two playmakers headline the list.

GRAIL (GRAL) stock plunges after NHS-Galleri trial miss for Galleri cancer test, which was added to the Hims & Hers (HIMS) platform earlier this month. Read more here.

Adam B’s experiment fails spectacularly in a viral gadget challenge. Alex Pretti spotted on camera moments before fatal shooting in Minneapolis Iran unveils mural warning of retaliation if US conducts ...

The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.